| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6110243 | Journal of Hepatology | 2009 | 7 Pages |
Abstract
The majority of protocol-defined Responders relapsed after 1 year when treatment was discontinued. Treatment with entecavir beyond 1 year provided continued virological and biochemical benefit.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Daniel Shouval, Ching-Lung Lai, Ting-Tsung Chang, Hugo Cheinquer, Paul Martin, Giampiero Carosi, Steven Han, Sabahattin Kaymakoglu, Ricardo Tamez, Joanna Yang, Daniel Tenney, Helena Brett-Smith,